ArticleUpdates in surgery2026
The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporal trends and future projections of pancreatic cancer mortality in Italy were examined to identify and characterize areas of interventions at medical and administrative level. Pancreatic cancer mortality data for 2005-2022 and demographic data including projections of Italian population through 2035 were retrieved from the Italian National Institute of Statistics public database. Age- and sex-specific mortality rates were projected until 2035 using Bayesian age-period-cohort analysis. The average annual number of deaths from pancreatic cancer in Italy is projected to increase through 2035, with a cumulative rise of +15.4% for males (M), and +13.0% for females (F), compared to the 2020-2022 period. While males consistently have higher Age Standardized Mortality Rates (ASMR) across all macro-regions, the national ASMR trend is projected to decrease slightly for both sexes (M: - 3.8%, F: - 0.6%). At a macro-regional level, those at lowest development index - southern Italy and islands-are the only macro-areas projected to experience an ASMR increase for both sexes. The largest projected ASMR increases were found for females in the islands (+ 22.7%) and for males in the southern regions (+ 18.8%). In contrast, the North-East regions showed the most favorable trend, with the largest projected ASMR decrease for females (- 8.7%). In parallel with population ageing, the absolute burden of pancreatic cancer mortality in Italy is projected to increase substantially, with significant macro-regional disparities. Addressing this growing challenge will require coordinated strategies and region-specific healthcare planning to optimize resource allocation and ensure equitable access to care.
Indexed as
Identifiers
42837076What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.